Welcome to our dedicated page for So-Young Intl SEC filings (Ticker: SY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
So-Young International Inc. (Nasdaq: SY) files with the U.S. Securities and Exchange Commission as a foreign private issuer, providing investors with detailed regulatory disclosures about its aesthetic treatment platform business in China. The company submits an annual report on Form 20-F, which includes audited consolidated financial statements, and furnishes Form 6-K current reports to transmit press releases and other information such as quarterly unaudited financial results and listing-related announcements.
In its filings, So-Young reports revenues from several categories, including aesthetic treatment services from its branded aesthetic centers, information and reservation services related to its online platform, sales of medical products and maintenance services, and other services. The filings also describe cost of revenues and operating expenses, giving a breakdown of how expenditures are allocated among aesthetic treatment services, information and reservation services, medical products and other services.
So-Young’s SEC materials often present both GAAP and non-GAAP financial measures. Non-GAAP income or loss from operations and non-GAAP net income or loss attributable to So-Young International Inc. are calculated by excluding items such as share-based compensation expenses and, in some periods, other adjustments including impairment of goodwill or long-term investments and related effects. The company provides reconciliations so readers can see how these measures relate to the most directly comparable GAAP figures.
Form 6-K submissions for SY also cover corporate and capital market developments, including notifications related to Nasdaq minimum bid price compliance and plans or amendments for ADS ratio changes. These filings help investors understand how So-Young manages its listing status and ADS structure while continuing to trade under the symbol SY.
On this SEC filings page, users can review So-Young’s 20-F annual report and 6-K current reports as they are furnished, while AI-powered tools can assist in summarizing key sections, comparing periods and highlighting changes in revenue composition, cost structure and non-GAAP adjustments across filings.
So-Young International Inc. COO Li Gefei exercised employee stock options on Class A ordinary shares of the company. On March 31, 2026, Li exercised options to acquire 46,153 Class A ordinary shares at an exercise price of US$0.01 per share, received in the form of American depositary shares, where 13 ADSs represent 10 Class A ordinary shares. Following the transactions, Li directly holds 46,153 Class A ordinary shares, reflecting a routine compensation-related option exercise with no open-market share sales reported.
So-Young International Inc. reported narrower losses on growing aesthetic services for Q4 and full-year 2025 but remains unprofitable. Fourth quarter revenues reached RMB460.7 million (US$65.9 million), up 24.8% from RMB369.2 million a year earlier, mainly driven by expansion of branded aesthetic centers.
Q4 net loss attributable to the company shrank sharply to RMB108.8 million (US$15.6 million) from RMB607.6 million, while non-GAAP net loss widened to RMB93.4 million (US$13.2 million) from RMB53.2 million. For 2025, revenues were RMB1,523.4 million (US$217.8 million), a 3.9% increase, and net loss improved to RMB242.3 million (US$34.6 million) from RMB589.5 million.
Full-year non-GAAP net loss expanded to RMB217.1 million (US$31.0 million) from RMB4.7 million as the company added new non-GAAP adjustment items. Cash, cash equivalents, restricted cash, term deposits and short-term investments totaled RMB936.4 million (US$133.9 million) as of December 31, 2025. The share repurchase program of up to US$25 million has been extended through March 31, 2027, with about 4.8 million ADSs repurchased in 2024 and 2025. For Q1 2026, So-Young expects aesthetic treatment services revenues between RMB268.0 million and RMB278.0 million, implying 171.2% to 181.3% growth over the prior year.
So-Young International Inc. director Shen Nan has filed an initial statement of beneficial ownership on Form 3. The filing lists Shen Nan as a director of the company but does not report any stock transactions or derivative holdings. This is a routine disclosure required when an individual becomes a reporting insider.
So-Young International Inc. director Zhang Haipeng filed an initial Form 3 as an insider of the company. The filing establishes his status as a reporting person under SEC rules but does not list any common stock or derivative security transactions or holdings.
So-Young International Inc. director and CMO Wang Bei filed an initial Form 3 detailing existing holdings in the company. The filing shows direct ownership of 145,185 American Depositary Shares.
Wang Bei also holds multiple stock options over Class A ordinary shares with an exercise price of $0.0100 per share, vesting in tranches and expiring between 2032 and 2035. The Form 3 is a disclosure of current positions and does not report any new purchases or sales.
So-Young International Inc. director He Chao filed an initial ownership report on Form 3. This filing establishes He Chao’s status as a director and provides a baseline disclosure of holdings in the company. The data show no reportable transactions or derivative positions in this filing.
So-Young International Inc.’s COO, Li Gefei, filed an initial Form 3 reporting holdings of stock options on the company’s Class A Ordinary Shares. The options carry a low exercise price of $0.0100 per share and vest in multiple tranches between 2025 and 2029, with expirations in 2034 and 2035. Individual option grants include underlying amounts such as 19,231, 9,615, 8,018, and 4,808 shares, all held directly. The filing reports these derivative positions and does not show any current share purchases or sales.
So-Young International Inc. director, CEO and interim CFO Jin Xing filed an initial statement of beneficial ownership, detailing his stake in the company. He indirectly holds 4,544,820 American Depositary Shares through Beauty & Health Holdings Limited, directly owns 3,767,692 Class A ordinary shares, and indirectly holds 12,000,000 Class B ordinary shares through the same entity. Each American Depositary Share represents 13 ADS for every 10 Class A ordinary shares, clarifying the structure of his economic interest. The filing reports holdings only and does not show any recent share purchases or sales.
So-Young International Inc. reported that Mr. Nan Huang has resigned from his position as Chief HR Officer, effective February 15, 2026, citing personal reasons. He will assist the company in ensuring a smooth transition of his responsibilities, and the company states that his resignation is not due to any dispute or disagreement with the organization.